Skip to main content

Roivant Sciences Ltd. (ROIV)

NASDAQ: ROIV · IEX Real-Time Price · USD
6.02 -0.09 (-1.47%)
Oct 15, 2021 4:00 PM EDT - Market closed
Market Cap1.34B
Revenue (ttm)29.95M
Net Income (ttm)n/a
Shares Out222.08M
EPS (ttm)-4.09
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume300,945
Open6.24
Previous Close6.11
Day's Range6.01 - 6.28
52-Week Range5.80 - 9.99
Betan/a
Analystsn/a
Price Targetn/a
Est. Earnings Daten/a

About ROIV

Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, warm autoimmune hemolytic anemia, thyroid eye diseases, sarcoidosis, and staph aureus bacteremia. The company was founded in 2014 and is based in London, the United Kingdom.

IndustryBiotechnology
Founded2014
Employees620
Stock ExchangeNASDAQ
Ticker SymbolROIV
Full Company Profile

Financial Performance

Financial Statements

News

Roivant Provides Corporate Updates

NEW YORK and BASEL, Switzerland, June 9, 2021 /PRNewswire/ -- Roivant Sciences today announced that Datavant, the leader in helping healthcare organizations securely connect their data, and Ciox Health,...

4 months ago - PRNewsWire

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Montes Archimedes Acquisition Corp. - MAAC

NEW YORK, May 21, 2021 /PRNewswire/ --  Juan Monteverde , founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018-2020 ISS Securities Class Action...

4 months ago - PRNewsWire

2 Best Biotech Stocks to Buy Now

Here's how a drug discovery company and a coronavirus vaccine drugmaker can boost investors' portfolios.

Other symbols:PFE
5 months ago - The Motley Fool

'SPACs Attack' Recap: Looking Back At 5 SPAC Deals, Rumors And Top Headlines

Last week featured five announced SPAC deals and several rumors. The week also had earnings from several well-known former SPACs.

Other symbols:LOKB
5 months ago - Benzinga

Roivant Sciences Gets SPAC Deal: What To Expect From This BioPharma, Health Technology Company

A drug discovery company with ownership stakes in several public and private biopharmaceutical companies is going public with a SPAC deal announced Monday morning. The SPAC Deal: Roviant Sciences announ...

5 months ago - Benzinga

Montes Archimedes Acquisition Corp. Announces the Separate Trading of its Shares of Class A Common Stock and Warrants...

MENLO PARK, Calif., Nov. 25, 2020 /PRNewswire/ -- Montes Archimedes Acquisition Corp. (Nasdaq: MAACU) (the "Company") announced that, commencing November 27, 2020, holders of the units sold in the Compa...

10 months ago - PRNewsWire

U.S. IPO Weekly Recap: Healthcare Dominates A 7 IPO Week

U.S. IPO Weekly Recap: Healthcare Dominates A 7 IPO Week

Other symbols:FUBOINTZKRONSPRBSTTK
1 year ago - Seeking Alpha

Montes Archimedes Acquisition Corp Announces Pricing of $400,000,000 Initial Public Offering

MENLO PARK, Calif., Oct. 6, 2020 /PRNewswire/ -- Montes Archimedes Acquisition Corp (the "Company" or "Montes Archimedes"), a special purpose acquisition company formed for the purpose of entering into ...

1 year ago - PRNewsWire